Bill Snyder

Vanderbilt’s Innovation Ambassadors help their colleagues change the world

Within the intellectual powerhouse that is Vanderbilt University and Vanderbilt University Medical Center thrives a group of doctors, engineers, computer scientists and others who also are visionaries, inventors and entrepreneurs. 

Advance in the treatment of acute heart failure identified

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

Diane Nash left, with Dorris Powell-Alexander, MD.

Civil Rights leader visits VUH Emergency Department

Legendary civil rights activist Diane Nash visited the emergency department at Vanderbilt University Medical Center on April 20 to acknowledge the naming of a physician team in her honor. 

Julie Bastarache, MD (photo by Donn Jones)

Julie Bastarache elected VP of clinical investigation society

Julie Bastarache, MD, Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center, has been elected vice president of the American Society for Clinical Investigation (ASCI) for 2024-2025.

Jeffrey Rathmell, PhD, and Melissa Wolf, PhD. (photo by Susan Urmy)

Study reveals potential new way to stop a common kidney cancer

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.

(iStock image)

Common AFib drug linked to higher bleeding risk 

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.

1 11 12 13 14 15 115